Hemorrhagic and endotoxic shock: a pathophysiologic approach to diagnosis and management.
D000136:Acid-Base Equilibrium; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D001794:Blood Pressure; D001810:Blood Volume; D001831:Body Temperature; D002302:Cardiac Output; D002496:Central Venous Pressure; D003404:Creatinine / Q000097:blood; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004573:Electrolytes / Q000097:blood; D006801:Humans; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D011674:Pulse; D012119:Respiration; D012771:Shock, Hemorrhagic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D012772:Shock, Septic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000601:surgery / Q000628:therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D004071:Digitalis Glycosides; D004573:Electrolytes; D014665:Vasodilator Agents; D003404:Creatinine; D007545:Isoproterenol